Carbonic Anhydrase Market Research Report 2024 | Valuates Reports

The global Carbonic Anhydrase market was valued at US$ 29 million in 2023 and is anticipated to reach US$ 37 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-19Y1505/Global_Carbonic_Anhydrase_Market_Insights_Forecast_to_2028

Carbonic Anhydrase Market Trends

The market for carbonic anhydrase is propelled by the enzyme's vital function in medicinal applications, specifically in the management of glaucoma, epilepsy, and altitude sickness. In order to prevent damage to the optic nerve and vision loss in glaucoma patients, carbonic anhydrase inhibitors are crucial for controlling intraocular pressure. The enzyme's importance in maintaining pH and ion balance also makes it essential for other physiological functions, which is why it is used to treat diseases like metabolic alkalosis.

The industrial and environmental industries now use carbonic anhydrase for a wider range of purposes because to developments in biotechnology. The enzyme is useful in combating climate change and lowering industrial carbon emissions because of its capacity to aid in CO2 capture and sequestration operations. Enzyme engineering innovations are increasing its stability and efficiency, which is increasing its application in a variety of sectors.

Carbonic Anhydrase Market Share

The market for carbonic anhydrase is dominated by North America, mostly because of the region's developed healthcare system and high glaucoma prevalence. Europe is right behind, having made large investments in biotechnology and environmentally conscious projects. It is anticipated that the Asia-Pacific area would increase quickly due to growing industrial uses, rising chronic illness prevalence, and rising healthcare awareness.

Purchase Regional Report: https://reports.valuates.com/request/regional/QYRE-Auto-19Y1505/Global_Carbonic_Anhydrase_Market_Insights_Forecast_to_2028

By Type
• 2000-3000 Units/Mg Protein
• ≥3000 Units/Mg Protein

By Application
• Hospital
• Laboratory

Key Companies
Prospec-Tany Technogene, MP Biomedicals, Yuanye Biology, Cida, Hangzhou Fanda Chemical, Jinpin Chemical Technology

View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-19Y1505/global-carbonic-anhydrase

Email Id:
Please reach us at sales@valuates.com

Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.